First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia
J Clin Oncol. 2026 Apr 6:JCO2501966. doi: 10.1200/JCO-25-01966. Online ahead of print. ABSTRACT PURPOSE: Patients with high-risk (HR) leukemia remain at substantial risk of early …